Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia.

Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia.

Item
http://www.wikidata.org/entity/Q33821379
The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.Almost all antipsychotics result in weight gain: a meta-analysis.A review of olanzapine pamoate.Long-acting injectable formulations of new-generation antipsychotics: a review from a clinical perspective.Drug safety evaluation of olanzapine pamoate.Weight gain and antipsychotics: a drug safety review.Olanzapine pamoate for the treatment of schizophrenia--a safety evaluation.Switching to olanzapine long-acting injection from either oral olanzapine or any other antipsychotic: comparative post hoc analyses.Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection.Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine.The Authorsʼ Reply
P2860

Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia.

Item
http://www.wikidata.org/entity/Q33821379
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Dose-associated changes in saf ...... n patients with schizophrenia.
@ast
Dose-associated changes in saf ...... n patients with schizophrenia.
@en
type
label
Dose-associated changes in saf ...... n patients with schizophrenia.
@ast
Dose-associated changes in saf ...... n patients with schizophrenia.
@en
prefLabel
Dose-associated changes in saf ...... n patients with schizophrenia.
@ast
Dose-associated changes in saf ...... n patients with schizophrenia.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Dose-associated changes in saf ...... n patients with schizophrenia.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932